John Vandermosten

John Vandermosten is a seasoned financial professional with extensive experience in equity research and analysis, particularly within the biotechnology and healthcare sectors. Currently serving as a Senior Biotechnology Analyst at Zacks Investment Research since March 2016, John specializes in publishing research on small-cap biotechnology firms, developing equity recommendations through comprehensive C-level interviews, and building investor relationships. Prior roles include Equity Analyst at Singular Research, Consultant at Coker Group, Portfolio Manager/Research Analyst at Westwood Holdings Group, and Portfolio Manager/Investment Analyst at the Teacher Retirement System of Texas. John's academic credentials include a Master's Degree in Economics/Business from Tulane University and a Bachelor's Degree from San Diego State University.